For help on how to get the results you want, see our search tips.
3 results
Medicine type
Exceptional circumstances Remove Exceptional circumstances filter
Accelerated assessment Remove Accelerated assessment filter
Biosimilar Remove Biosimilar filter
Application type
Initial authorisation Remove Initial authorisation filter
Categories
Human Remove Human filter
-
List item
Summary of opinion: Lextemy
bevacizumab, opinion date: 25/02/2021, Positive, Last updated: 26/02/2021 -
List item
Summary of opinion: Libmyris
adalimumab, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Hukyndra
adalimumab, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021